Circular 18 of 2024, issued by the National Commission for Medicine’s and Medical Devices Prices (NCMMDP), marks a significant shift in the methodology for regulating medicine prices outlined in Circular 03/2013. Here’s a concise breakdown of the key stages:
- =Relevant Market Definition: products with the same active pharmaceutical ingredient, strength, Pharmaceutical Dosage Form, and administration route are grouped into relevant markets.
- =Relevant Market Qualification: markets are assessed based on market share and concentration.
- =Offeror Price Calculation and National Reference Price (NRP) Determination: offeror prices are calculated based on total sales and quantities sold.
- =Basis Price (BP) Determination.
- =Maximum Sales Price (MSP): MSP is calculated by adding the Adjustment Margin to the BP.
